Other
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10
CVS Health Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 increased by 6.9% to $2.9B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.0%, from $2.71B to $2.9B.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ2 2019
Last reportedQ1 2026May 6, 2026
Metric ID:
other_available_for_sale_securities_debt_maturities_afte_b0420bHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.78B | $4.86B | $4.52B | $4.02B | $3.73B | $3.96B | $3.9B | $3.52B | $3.7B | $3.31B | $3.06B | $2.71B | $2.56B | $2.71B | $2.9B |
| QoQ Change | — | +1.6% | -7.0% | -10.9% | -7.2% | +6.1% | -1.4% | -9.9% | +5.3% | -10.6% | -7.4% | -11.6% | -5.5% | +5.9% | +6.9% |
| YoY Change | — | — | — | -15.8% | -23.1% | -12.3% | -2.9% | -5.8% | -6.5% | -15.2% | -12.9% | -26.8% | -22.6% | -11.5% | +7.0% |
Range$2.56B – $4.86B
CAGR-13.3%
Avg YoY Growth-12.4%
Median YoY Growth-12.6%
Current Streak2 quarters growth
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 at Other Companies
Frequently Asked Questions
- What is CVS Health's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year 10?
- CVS Health (CVS) reported debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year 10 of $2.9B in Q1 2026.
- How has CVS Health's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year 10 changed year-over-year?
- CVS Health's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year 10 increased by 7.0% year-over-year, from $2.71B to $2.9B.